埃塞俄比亚糖尿病患者微血管并发症患病率及相关因素:系统回顾和荟萃分析

IF 2.9 4区 医学 Q2 PERIPHERAL VASCULAR DISEASE Microvascular research Pub Date : 2025-03-01 Epub Date: 2024-12-26 DOI:10.1016/j.mvr.2024.104779
Getinet Kumie, Marye Nigatie, Abebaw Alamrew, Solomon Gedifie, Woldeteklehaymanot Kassahun, Abdu Jemal, Chalie Mulugeta, Sisay Ayana, Mulat Ayele, Eyob Shitie, Belaynesh Gtsadik, Wagaw Abebe, Agenagnew Ashagre, Tadesse Misganaw, Zelalem Dejazmach, Assefa Sisay, Zelalem Asmare, Muluken Gashaw, Ermias Getachew, Yalewayker Gashaw, Selamyhun Tadesse, Biruk Beletew Abate, Atitegeb Abera Kidie, Melesse Abate Reta
{"title":"埃塞俄比亚糖尿病患者微血管并发症患病率及相关因素:系统回顾和荟萃分析","authors":"Getinet Kumie, Marye Nigatie, Abebaw Alamrew, Solomon Gedifie, Woldeteklehaymanot Kassahun, Abdu Jemal, Chalie Mulugeta, Sisay Ayana, Mulat Ayele, Eyob Shitie, Belaynesh Gtsadik, Wagaw Abebe, Agenagnew Ashagre, Tadesse Misganaw, Zelalem Dejazmach, Assefa Sisay, Zelalem Asmare, Muluken Gashaw, Ermias Getachew, Yalewayker Gashaw, Selamyhun Tadesse, Biruk Beletew Abate, Atitegeb Abera Kidie, Melesse Abate Reta","doi":"10.1016/j.mvr.2024.104779","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus (DM) is a metabolic abnormality affecting 537 million people worldwide. Poor glycemic control, longer duration, and poor medication adherence increased the risk of DM complications. Comprehensive evidence on the pooled prevalence of microvascular complications in DM patients in Ethiopia is not available. Furthermore, individual study findings for the prevalence of microvascular complications in DM patients, and associated factors were not consistent.</p><p><strong>Objective: </strong>This systemic review and meta-analysis aimed to assess the pooled prevalence of microvascular complications in DM patients, and its associated risk factors in Ethiopia.</p><p><strong>Methods: </strong>Systematic search on Scopus, PubMed, Science Direct electronic database, Google Scholar search engine, and library registration was used to identify relevant studies following reviews and meta-analysis guidelines. Microsoft Excel spreadsheets were used to extract data, and Extracted data was analyzed using STATA software version 17.0. A Sensitivity analysis was conducted to assess the role of each study in the final result and the presence of publication bias was assessed by Egger's test. Heterogeneity across studies was checked by Cochran's Q statistic and I2 statistics and significant heterogeneity was assessed using subgroup analysis.</p><p><strong>Results: </strong>The pooled prevalence of microvascular complications in DM patients was 32.89 % (95 % CI: 28.17-37.60). In addition, the pooled prevalence of retinopathy, neuropathy, and nephropathy in DM patients was 17.16 % (95 % CI: 12-22 %), 10.49 % (95 % CI: 8-13 %) and 11.52 % (95 % CI: 9-15 %) respectively. Age >60 years old (AOR = 1.08 (95%CI = 1.02-1.15), longer duration of DM (AOR = 1.57 (95 % CI = 1.31-1.84), poor glycemic control (AOR = 2.21 (95 % CI = 1.52-2.91), poor adherence to diabetic medications (AOR = 3.61 (95 % CI = 1.83-5.38) and presence of hypertension (AOR = 2.26 (95 % CI = 1.73-2.80) ware associated risk factors for microvascular complications in DM patients.</p><p><strong>Concussion: </strong>Around one-third of DM patients had one or more microvascular complications. Patients with advanced age, longer duration of DM, poor glycemic control, poor medication adherence, and comorbidity like hypertension should be targeted to tackle the occurrence and severity of microvascular complications in DM patients.</p><p><strong>Protocol registration: </strong>The review protocol was developed and was registered with PROSPERO registration number (CRD42023486459).</p>","PeriodicalId":18534,"journal":{"name":"Microvascular research","volume":" ","pages":"104779"},"PeriodicalIF":2.9000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of microvascular complications and associated factors among diabetes mellitus patients in Ethiopia: Systematic review and meta-analysis.\",\"authors\":\"Getinet Kumie, Marye Nigatie, Abebaw Alamrew, Solomon Gedifie, Woldeteklehaymanot Kassahun, Abdu Jemal, Chalie Mulugeta, Sisay Ayana, Mulat Ayele, Eyob Shitie, Belaynesh Gtsadik, Wagaw Abebe, Agenagnew Ashagre, Tadesse Misganaw, Zelalem Dejazmach, Assefa Sisay, Zelalem Asmare, Muluken Gashaw, Ermias Getachew, Yalewayker Gashaw, Selamyhun Tadesse, Biruk Beletew Abate, Atitegeb Abera Kidie, Melesse Abate Reta\",\"doi\":\"10.1016/j.mvr.2024.104779\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Diabetes mellitus (DM) is a metabolic abnormality affecting 537 million people worldwide. Poor glycemic control, longer duration, and poor medication adherence increased the risk of DM complications. Comprehensive evidence on the pooled prevalence of microvascular complications in DM patients in Ethiopia is not available. Furthermore, individual study findings for the prevalence of microvascular complications in DM patients, and associated factors were not consistent.</p><p><strong>Objective: </strong>This systemic review and meta-analysis aimed to assess the pooled prevalence of microvascular complications in DM patients, and its associated risk factors in Ethiopia.</p><p><strong>Methods: </strong>Systematic search on Scopus, PubMed, Science Direct electronic database, Google Scholar search engine, and library registration was used to identify relevant studies following reviews and meta-analysis guidelines. Microsoft Excel spreadsheets were used to extract data, and Extracted data was analyzed using STATA software version 17.0. A Sensitivity analysis was conducted to assess the role of each study in the final result and the presence of publication bias was assessed by Egger's test. Heterogeneity across studies was checked by Cochran's Q statistic and I2 statistics and significant heterogeneity was assessed using subgroup analysis.</p><p><strong>Results: </strong>The pooled prevalence of microvascular complications in DM patients was 32.89 % (95 % CI: 28.17-37.60). In addition, the pooled prevalence of retinopathy, neuropathy, and nephropathy in DM patients was 17.16 % (95 % CI: 12-22 %), 10.49 % (95 % CI: 8-13 %) and 11.52 % (95 % CI: 9-15 %) respectively. Age >60 years old (AOR = 1.08 (95%CI = 1.02-1.15), longer duration of DM (AOR = 1.57 (95 % CI = 1.31-1.84), poor glycemic control (AOR = 2.21 (95 % CI = 1.52-2.91), poor adherence to diabetic medications (AOR = 3.61 (95 % CI = 1.83-5.38) and presence of hypertension (AOR = 2.26 (95 % CI = 1.73-2.80) ware associated risk factors for microvascular complications in DM patients.</p><p><strong>Concussion: </strong>Around one-third of DM patients had one or more microvascular complications. Patients with advanced age, longer duration of DM, poor glycemic control, poor medication adherence, and comorbidity like hypertension should be targeted to tackle the occurrence and severity of microvascular complications in DM patients.</p><p><strong>Protocol registration: </strong>The review protocol was developed and was registered with PROSPERO registration number (CRD42023486459).</p>\",\"PeriodicalId\":18534,\"journal\":{\"name\":\"Microvascular research\",\"volume\":\" \",\"pages\":\"104779\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Microvascular research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.mvr.2024.104779\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microvascular research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.mvr.2024.104779","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

背景:糖尿病(DM)是一种影响全球5.37亿人的代谢异常。血糖控制不良、持续时间较长和药物依从性差增加了糖尿病并发症的风险。埃塞俄比亚糖尿病患者微血管并发症的综合流行率尚无全面证据。此外,关于糖尿病患者微血管并发症患病率及其相关因素的个体研究结果并不一致。目的:本系统综述和荟萃分析旨在评估埃塞俄比亚糖尿病患者微血管并发症的总患病率及其相关危险因素。方法:采用系统检索Scopus、PubMed、Science Direct电子数据库、谷歌Scholar搜索引擎和图书馆注册等方法,根据综述和meta分析指南筛选相关研究。采用Microsoft Excel电子表格提取数据,使用STATA 17.0版本软件对提取数据进行分析。进行敏感性分析以评估每项研究在最终结果中的作用,并通过Egger检验评估发表偏倚的存在。采用Cochran’s Q统计量和I2统计量检验各研究的异质性,并采用亚组分析评估显著异质性。结果:糖尿病患者微血管并发症的总发生率为32.89 %(95 % CI: 28.17-37.60)。此外,汇集的视网膜病发生率,神经病变,并在糖尿病肾病患者是17.16 %( 95 % CI: 12日至22日%),10.49 %(95 % CI: 8日至13日 %)和11.52 %(95 % CI: 9 - 15 %)。年龄> 60岁 岁(AOR = 1.08 (95% CI = 1.02 - -1.15),长期的DM (AOR = 1.57 (95 CI  % = 1.31 - -1.84),血糖控制不佳(AOR = 2.21 (95 CI  % = 1.52 - -2.91),可怜的坚持糖尿病药物(AOR = 3.61 (95 CI  % = 1.83 - -5.38)和高血压(AOR = 2.26 (95 CI  % = 1.73 - -2.80)制品相关的糖尿病患者微血管并发症的危险因素。脑震荡:大约三分之一的糖尿病患者有一种或多种微血管并发症。对于年龄较大、糖尿病持续时间较长、血糖控制较差、药物依从性较差、高血压等合并症患者,应针对糖尿病患者微血管并发症的发生及严重程度进行针对性治疗。方案注册:审查方案已制定并以PROSPERO注册号(CRD42023486459)注册。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Prevalence of microvascular complications and associated factors among diabetes mellitus patients in Ethiopia: Systematic review and meta-analysis.

Background: Diabetes mellitus (DM) is a metabolic abnormality affecting 537 million people worldwide. Poor glycemic control, longer duration, and poor medication adherence increased the risk of DM complications. Comprehensive evidence on the pooled prevalence of microvascular complications in DM patients in Ethiopia is not available. Furthermore, individual study findings for the prevalence of microvascular complications in DM patients, and associated factors were not consistent.

Objective: This systemic review and meta-analysis aimed to assess the pooled prevalence of microvascular complications in DM patients, and its associated risk factors in Ethiopia.

Methods: Systematic search on Scopus, PubMed, Science Direct electronic database, Google Scholar search engine, and library registration was used to identify relevant studies following reviews and meta-analysis guidelines. Microsoft Excel spreadsheets were used to extract data, and Extracted data was analyzed using STATA software version 17.0. A Sensitivity analysis was conducted to assess the role of each study in the final result and the presence of publication bias was assessed by Egger's test. Heterogeneity across studies was checked by Cochran's Q statistic and I2 statistics and significant heterogeneity was assessed using subgroup analysis.

Results: The pooled prevalence of microvascular complications in DM patients was 32.89 % (95 % CI: 28.17-37.60). In addition, the pooled prevalence of retinopathy, neuropathy, and nephropathy in DM patients was 17.16 % (95 % CI: 12-22 %), 10.49 % (95 % CI: 8-13 %) and 11.52 % (95 % CI: 9-15 %) respectively. Age >60 years old (AOR = 1.08 (95%CI = 1.02-1.15), longer duration of DM (AOR = 1.57 (95 % CI = 1.31-1.84), poor glycemic control (AOR = 2.21 (95 % CI = 1.52-2.91), poor adherence to diabetic medications (AOR = 3.61 (95 % CI = 1.83-5.38) and presence of hypertension (AOR = 2.26 (95 % CI = 1.73-2.80) ware associated risk factors for microvascular complications in DM patients.

Concussion: Around one-third of DM patients had one or more microvascular complications. Patients with advanced age, longer duration of DM, poor glycemic control, poor medication adherence, and comorbidity like hypertension should be targeted to tackle the occurrence and severity of microvascular complications in DM patients.

Protocol registration: The review protocol was developed and was registered with PROSPERO registration number (CRD42023486459).

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Microvascular research
Microvascular research 医学-外周血管病
CiteScore
6.00
自引率
3.20%
发文量
158
审稿时长
43 days
期刊介绍: Microvascular Research is dedicated to the dissemination of fundamental information related to the microvascular field. Full-length articles presenting the results of original research and brief communications are featured. Research Areas include: • Angiogenesis • Biochemistry • Bioengineering • Biomathematics • Biophysics • Cancer • Circulatory homeostasis • Comparative physiology • Drug delivery • Neuropharmacology • Microvascular pathology • Rheology • Tissue Engineering.
期刊最新文献
Functional heterogeneity of endothelium-dependent vasorelaxation in different order branches of mesenteric artery in female/male mice. Muscle tissue oxygenation in individuals with peripheral arterial disease of different walking abilities: An exploratory study. Retinal microvascular dysfunction in systemic sclerosis. Prevalence of microvascular complications and associated factors among diabetes mellitus patients in Ethiopia: Systematic review and meta-analysis. Low-grade hemodilution improves the microcirculatory function in surgical patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1